产品中心
Clopidogrel Bisulfate Tablets
This product is indicated for the prevention of atherothrombosis events in: 1. Patients with recent myocardial infarction, recent ischemic stroke or confirmed peripheral arterial disease. 2. Patients with acute coronary syndrome. 3. Patients with non-ST-segment elevation acute coronary syndrome (including unstable angina or non-Q wave myocardial infarction), including patients with stent placement following percutaneous coronary intervention. 4. Patients with ST-segment elevation acute coronary syndrome.

Clopidogrel Bisulfate Tablets

< 1 >